KeyBank National Association’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-19,778
Closed -$321K 1072
2018
Q3
$321K Sell
19,778
-42,963
-68% -$614K ﹤0.01% 882
2018
Q2
$809K Hold
62,741
﹤0.01% 612
2018
Q1
$781K Buy
62,741
+22,497
+56% +$274K ﹤0.01% 624
2017
Q4
$562K Hold
40,244
﹤0.01% 714
2017
Q3
$676K Sell
40,244
-15,018
-27% -$244K ﹤0.01% 692
2017
Q2
$930K Buy
55,262
+9,282
+20% +$139K 0.01% 613
2017
Q1
$712K Hold
45,980
﹤0.01% 708
2016
Q4
$687K Hold
45,980
﹤0.01% 726
2016
Q3
$578K Hold
45,980
﹤0.01% 778
2016
Q2
$414K Buy
45,980
+22,795
+98% +$223K ﹤0.01% 843
2016
Q1
$230K Hold
23,185
﹤0.01% 995
2015
Q4
$267K Buy
23,185
+90
+0.4% +$1.11K ﹤0.01% 991
2015
Q3
$312K Buy
+23,095
New +$313K ﹤0.01% 938

Other funds holding OXFD

KeyBank National Association's OXFD Position: Q4 2018 in Review

KeyBank National Association sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2018, closing a stake of 19,778 shares — an estimated $321K sold.

KeyBank National Association first reported a position in OXFD in Q3 2015 and held it in 13 quarters. The position peaked at $930K in Q2 2017. 82 funds tracked by Wall St. Rank hold OXFD as of Q4 2018.

  • KeyBank National Association reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2018 after selling out during the quarter.
  • KeyBank National Association sold 19,778 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2018, an estimated $321K.
  • KeyBank National Association first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2015 and held it in 13 quarters.
  • KeyBank National Association's Oxford Immunotec Global PLC Ordinary Shares position peaked at $930K in Q2 2017.
  • 82 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2018.

Based on KeyBank National Association's 13F filing for Q4 2018, filed 30 Jan 2019.